Alvotech (ALVO) Change in Account Payables (2021 - 2025)
Alvotech (ALVO) reported Change in Account Payables of $73.2 million for Q4 2025, up 634.86% on a YoY basis from $10.0 million in Q4 2024, and up 260.3% quarter-over-quarter from -$45.7 million in Q3 2025.
Alvotech (ALVO) Change in Account Payables (2021 - 2025) Analysis & Trends
Alvotech has reported Change in Account Payables for 5 years, with the latest figure at $73.2 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables rose 634.86% year-over-year to $73.2 million; the trailing twelve-month figure through Dec 2025 stood at $45.3 million (up 208.84% YoY), and the FY2025 full-year result was $45.3 million, up 430.87% from the prior year.
- Change in Account Payables for Q4 2025 stood at $73.2 million, up from -$45.7 million in the prior quarter.
- The five-year high for Change in Account Payables was $73.2 million in Q4 2025, with the low at -$45.7 million in Q3 2025.
- Historically, Change in Account Payables has averaged $3.8 million across 5 years, with a median of $5.1 million in 2021.
- The largest YoY upside for Change in Account Payables was 634.86% in 2025 against a maximum downside of 639.5% in 2025.
- Alvotech's Change in Account Payables stood at $2.9 million in 2021, then surged by 127.31% to $6.6 million in 2022, then soared by 393.11% to $32.3 million in 2023, then slumped by 142.35% to -$13.7 million in 2024, then soared by 634.86% to $73.2 million in 2025.
- The last three Change in Account Payables figures came in at $73.2 million (Q4 2025), -$45.7 million (Q3 2025), and $46.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Alvotech | 12.16 Mn | -160.20 Mn | -22.39 Mn | 73.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 73.25 Mn |
| Dec 31, 2025 | 73.25 Mn |
| Sep 30, 2025 | -45.69 Mn |
| Sep 30, 2025 | -45.69 Mn |
| Jun 30, 2025 | 46.68 Mn |
| Jun 30, 2025 | 46.68 Mn |
| Mar 31, 2025 | -28.93 Mn |
| Mar 31, 2025 | -28.93 Mn |
| Dec 31, 2024 | -13.70 Mn |
| Dec 31, 2024 | -13.70 Mn |
| Sep 30, 2024 | -6.18 Mn |
| Sep 30, 2024 | -6.18 Mn |
| Jun 30, 2024 | 7.17 Mn |
| Jun 30, 2024 | 7.17 Mn |
| Mar 31, 2024 | -28.93 Mn |
| Mar 31, 2024 | -28.93 Mn |
| Dec 31, 2023 | 32.34 Mn |
| Dec 31, 2023 | 32.34 Mn |
| Jun 30, 2023 | 12.42 Mn |
| Jun 30, 2023 | 12.42 Mn |